
|
|
| Managing Cancer Care: Strategies to Improve Outcomes and Lower Costs |
Table
of Contents
Photo
of Book
Written
By
Written For
Shipping Information
Related Publications |
|
| Order
Now (Secure Site) |
 |
Print
Version |
 |
PDF
Version* |
 |
View
Cart |
|
Place an order or get more information at 800-521-4323 |
Price: $69
Pages: 145
PDF Version: 1,465 KB
ISBN: 1-933801-23-9
© 2007
Pub Code: BMCC-ENLAD |
|
*PDF Version
After you submit your order,
a link
will appear directing you
to download the PDF file of the book. This link will be accessible
only for 24 hours, so be sure to save the file to your computer.
Shipping will NOT be charged for this item. |
As
health care costs continue to swell, one of the most costly and complicated kinds of health
care expenses is oncology care. Such treatments cost about $200 billion
annually, with costs growing each year. While manufacturers have made tremendous strides in treating various types of cancers and their side effects, these therapies come at a high price for payers.
Managing Cancer Care: Strategies to Improve Outcomes and Lower Costs examines some of the management strategies and pricing methodologies that health plans have been instituting in hopes of reining in costs, as well as the federal government’s role in reimbursement.
Filled
with articles on recent developments from companies leading the way
in oncology management including an extensive presentation
from Aetna Specialty Pharmacy with facts, figures and program design
details this valuable report provides insight on the programs
health plans and PBMs have put in place, and how payers are responding.
Against
a backdrop of great emotional drain on patients and their families,
these fast-changing business conditions are demanding that health
plans devote increasing attention to oncology management. Managing Cancer Care: Strategies to Improve Outcomes and Lower Costs paints a clear picture of the issues facing this market. Order your
copy today!
Table
of Contents
Introduction
1. Oncology Cost/Reimbursement Issues
-
With Its Entrance to Anti-Emetic Market, Generic Zofran Draw Payers’ Interest
-
Medicare Pricing Offers Extra Incentive for Ondansetron Use
-
Payers Use Drug Discounts, SP Networks to Curb Oncology Costs
-
Effective Oncology Management Strategies for Health Plans
-
Some Providers Learn to Live With CAP; Vendor Earns CMS’s Respect
-
Drilling Down on Cell-Stimulating Factor Data May Decrease Costs, Improve Care
-
Federal Government Takes an Interest in Anemia Drugs
-
How Much of CSFs Should Be Used?
-
Experts: Having Medical Policy, Auditing Use Help Ensure Proper Herceptin Prescribing
-
What Are Plans Doing on Herceptin?
-
OIG Report Says Part B Pay for Oncology Drugs Could Be Cut
-
Experts Offer Advice, Data on Managing Oncology Drug Spend
-
Aetna Specialty Pharmacy: The Integrated Solution
-
Payer Strategies for Navigating Oncology Market Challenges
2. Oncology Management Strategies
-
Many Plans Covering Tykerb Are Also Using Prior Authorization
-
UnitedHealthcare Carves Out, Takes Three-Pronged Approach to Oncology
-
Concern Grows on ESAs as Studies Show Rise in Deaths; USP DI Delists One Use
-
ESAs Represent Huge Financial Expense
-
Specialty Pharmacy Distributors Sign New Oncology Deals
-
ICORE Summit Identifies New Direction for Oncology Management
-
Interest in Oncology DM Increases, but Only as Part of One-Stop Shopping Solution
-
The Cancer DM Market: What It Is, and What It Isn’t
-
Medicare Brings Opportunities for SPs in Oncology Management
3. Oncology Market Report
-
Clinical Data Launches Rituximab Diagnostic Test for NHL Patients
-
UHC Covers Oncotype Dx Test
-
Aetna Sets Payment Rates for Breast Cancer Diagnostic Test
-
Focus on Pyschosocial Oncology Increases; Reimbursement, Other Challenges Exist
-
How Are Payers Handling Psychosocial Oncology Coverage?
-
Drug Appropriateness, Oral Drugs Pose Major Oncology Concerns
-
OTN Survey: Community-Based Oncologists Support P4P, EMRs
-
Just-Formed Oncology Specialty Pharmacy May Be Indicative of New Focus in Industry
-
ICORE Deal May Be Sign of New Component In Specialty Pharmacy Acquisition Market
-
Great-West Unveils Study on Oncology Product Preferencing
-
Cancer Drug Costs, Treatments, Concerns Continue to Increase
-
More MCOs Are Focusing on Oncology Strategies
Written
By
This
book was written by the editorial staff of AIS.
The
presentation from Aetna Specialty Pharmacy was written by Rebecca
M. Shanahan, executive vice president and general manager of Aetna
Specialty Pharmacy, which she helped start up in 2005. Aetna Specialty
Pharmacy dispenses specialty pharmaceuticals and, through clinical
informatics and therapy management, supports patients' adherence,
persistence and compliance on more than 1,000 oral, injectable and
infusible therapies. From 2002 to 2005, Ms. Shanahan served as executive
vice president for Priority Healthcare Corp., where she had numerous
responsibilities, including strategic initiatives for Priority. Her
portfolio of responsibilities included strategic partnerships, corporate
development, acquisitions and mergers, legal services, payer relations
and sales, reimbursement and government services.
Written
For
- Health
plan executives; strategic planners; product development, provider
contracting and marketing executives; and pharmacy and medical
directors
- Human resource
and benefits executives at employers
- Specialty
pharmacy CEOs, CFOs and marketing and contracting directors
- PBM and pharmacy
benefit administrator (PBA) executives
- Consultants
- Pharmaceutical
manufacturer marketers, strategic planners and contracting directors
- Physicians
- Third-party
administrator executives
Shipping
Information
PDF
Version:
If you place your order through our secure shopping cart, a
link will appear directing you to download
the PDF file of the book. This link will be accessible only for 24
hours, so be sure to save the file to your computer.
If you place your order via phone, fax or mail, the PDF version will
be e-mailed to you when your order is
processed (usually within 1 business day). Shipping costs will not
be charged for this item.
Print
Version:
This item is shipped via UPS. Please give us your street address when
you order (UPS does not deliver to PO boxes). You should receive your
order within 5-7 business days. Shipping cost is $5 per item.
Print
Rush Orders:
Please call us at 800-521-4323 to place a rush order. We will overnight
your order for an additional charge of $30, or you can give us your
FedEx or UPS account number and we will charge the shipping to your
account. Rush orders placed after 3:00pm EST will not be shipped
out until the next business day.
Related
Publications
|
|
|